Fulcrum Therapeutics Inc. (FULC) Misses Q3 EPS by 2c
Tweet
Share
E-mail
Get Alerts FULC Hot Sheet
Join SI Premium – FREE
Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q3 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vipshop Holdings (VIPS) Misses Q2 EPS by 103c; misses on guidance
- Wolfe Research Upgrades Moderna (MRNA) to Peerperform
- UBS Upgrades Smoore International Holdings Limited (6969:HK) (SMORF) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
